Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy.
about
Cardiac and renal cell therapies: similarities and differencesStem Cell-Based Therapies in Chagasic CardiomyopathyCell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directionsCurrent stem cell delivery methods for myocardial repairImaging: guiding the clinical translation of cardiac stem cell therapyTracking of stem cells in vivo for cardiovascular applications.The effectiveness of rigid pericardial endoscopy for minimally invasive minor surgeries: cell transplantation, epicardial pacemaker lead implantation, and epicardial ablation.Adipose Stem Cells Display Higher Regenerative Capacities and More Adaptable Electro-Kinetic Properties Compared to Bone Marrow-Derived Mesenchymal Stromal Cells.Bone marrow cells for cardiac regeneration and repair: current status and issues.Bone marrow cell transplant does not prevent or reverse murine liver cirrhosis.Cardiac repair with adult bone marrow-derived cells: the clinical evidence.Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease.Unchain my heart: the scientific foundations of cardiac repairCell-based therapy for heart disease: a clinically oriented perspectiveTransplanted bone marrow stem cells relocate to infarct penumbra and co-express endogenous proliferative and immature neuronal markers in a mouse model of ischemic cerebral strokeProinflammatory stem cell signaling in cardiac ischemiaTransendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.Human CD34+ cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of actionMesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment.The role of stem cells in cardiac regeneration.Stem cell therapy and breast cancer treatment: review of stem cell research and potential therapeutic impact against cardiotoxicities due to breast cancer treatment.Production of stem cells with embryonic characteristics from human umbilical cord blood.MRI-3D ultrasound-X-ray image fusion with electromagnetic tracking for transendocardial therapeutic injections: in-vitro validation and in-vivo feasibility.Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.Cardiac regeneration using pluripotent stem cells--progression to large animal models.Impact of intracoronary reinfusion of bone marrow-derived mononuclear progenitor cells on cardiopulmonary exercise capacity in patients with chronic postinfarction heart failure.Clinical trials of cardiac repair with adult bone marrow- derived cells.Stem cell therapy: MRI guidance and monitoring.Stem and progenitor cell-based therapy in ischaemic heart disease: promise, uncertainties, and challengesA dosing study of bone marrow mononuclear cells for transendocardial injection in a pig model of chronic ischemic heart disease.The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disordersMulticenter randomized trial of cell therapy in cardiopathies - MiHeart Study.In vivo functional and transcriptional profiling of bone marrow stem cells after transplantation into ischemic myocardiumRecent advances in the diagnosis and treatment of acute myocardial infarctionTracking stem cells for cardiovascular applications in vivo: focus on imaging techniques.Clinical trials with adult stem/progenitor cells for tissue repair: let's not overlook some essential precautions.Bone marrow stem cell mobilization in stroke: a 'bonehead' may be good after all!Stem cell therapy for the heart.Regenerative medicine for cardiovascular disorders-new milestones: adult stem cells.Getting to the heart of myocardial stem cells and cell therapy.
P2860
Q26851704-9409852A-5EE4-4D51-BAFB-6CF614AB1891Q26852985-2A0ACBA5-BBA9-48DC-8537-837FC87B84E3Q27001159-405467ED-86E4-4058-A181-25FEE5C50150Q27004753-BEDFF132-2C76-4A62-930D-39CBC7E7E016Q27008410-A5FFBC52-92BC-46CE-A267-8979515100E9Q30443013-1AD6EAC8-B5B6-43D6-8E93-78CDE274816EQ30532030-1543CBD9-AC76-4CB8-B383-420A162E55E5Q30829638-DC8D76FC-DB64-4BBE-94DB-B5337FECE09FQ33254416-73AA1612-E00E-4ABF-B4EC-13EF711AF1D2Q33391719-75D9ADDE-21C9-460F-B74D-CEF01FBDE531Q33406980-2E7F6B93-9993-4257-B346-41CFA035DBA0Q33490304-F86E6846-601B-4E82-83AC-680A6BA883A4Q33683767-8D6FB6DD-CEC3-428E-8829-EF969A775D35Q33713519-D113B1CD-3882-4822-BFB5-FC1128FC912CQ33727333-8B1C3FFB-8EF9-481D-8078-EE04EBC1CE6CQ33858319-212D3D75-8784-4B38-96CB-07E13BF05CEDQ33950809-31702D41-86FC-4BD8-AE37-DB79E3D2C50BQ34012519-21ED700F-7A73-4FC1-AF45-43C570EE92B3Q34402072-CE2C90A9-A32A-4651-B631-6543A3556499Q34405511-7CD01D87-6D22-467C-869A-341C4177D551Q34441749-9F53E007-BB11-4E49-88FD-382232699BD2Q34442632-4222CE5F-BCB9-4661-8A51-764BA0AB8330Q34546508-588A1151-D568-49F6-BCED-43EF2D21BF71Q34564111-71F6BA1A-8202-49A8-872B-F4B24C9CCDC7Q34617472-CA8DA7B3-EA99-46AB-A6AC-D71B9194F21EQ34683330-AC330F5E-1E8A-4859-9A47-D150B4592BFAQ34786321-E56B6FD8-9073-44F8-8E79-0E2C695F9314Q34786978-463CD646-5ED6-4BBC-9955-7E462643823AQ34981433-7381287B-64D5-4E0A-AB53-AA1DEEE93455Q35039526-673A898E-EF8D-4134-B902-4031C18E57C7Q35256491-77ECE50C-60AD-4240-951F-60564455221AQ35613592-ABB36ECC-DF47-43E2-B5D3-DE68BF70BA61Q35621666-36A3EDDA-D077-4E30-8198-22C5A2E54A63Q35626702-7ED61459-B450-4EE4-8AF8-C5411699E1D1Q35691795-F11B43EA-C0F5-4099-9DB9-2B95E7B4D42DQ35751008-74299A6E-3117-41C4-A908-36ED3CC2A9A9Q35792838-56ACB600-7B41-4A82-A937-8F8AE7504B7DQ35980614-0F8280EE-7045-4EBA-BF47-8597C3D76329Q36462071-C85D0186-C9D9-4E57-84B7-4907F2A8E7BDQ36540656-1DDFFB7E-BAB4-4331-BF65-1039465D690D
P2860
Improved exercise capacity and ischemia 6 and 12 months after transendocardial injection of autologous bone marrow mononuclear cells for ischemic cardiomyopathy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Improved exercise capacity and ...... s for ischemic cardiomyopathy.
@en
Improved exercise capacity and ...... s for ischemic cardiomyopathy.
@nl
type
label
Improved exercise capacity and ...... s for ischemic cardiomyopathy.
@en
Improved exercise capacity and ...... s for ischemic cardiomyopathy.
@nl
prefLabel
Improved exercise capacity and ...... s for ischemic cardiomyopathy.
@en
Improved exercise capacity and ...... s for ischemic cardiomyopathy.
@nl
P2093
P1433
P1476
Improved exercise capacity and ...... s for ischemic cardiomyopathy.
@en
P2093
Andre L S Sousa
Antonio C Carvalho
Claudio T Mesquita
Emerson C Perin
Fernando O D Rangel
Guilherme V Silva
Hans F R Dohmann
Hans J F Dohmann
James T Willerson
Joao A R Assad
P304
P356
10.1161/01.CIR.0000138398.77550.62
P407
P433
11 Suppl 1
P577
2004-09-01T00:00:00Z